Moreover, unlike other “druggable” nuclear hormone receptors within the same subfamily (e.g. AR, estrogen receptor [ER]), GR is not selectively expressed or perhaps even overexpressed in cancer compared to normal tissues. This evidence concerns the gene ESR1 and cancer.